|
1
|
Vaidya S, Hibbert CL, Kinter E and Boes S:
Identification of key cost generating events for idiopathic
pulmonary fibrosis: A systematic review. Lung. 195:1–8. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Renzoni E, Srihari V and Sestini P:
Pathogenesis of idiopathic pulmonary fibrosis: Review of recent
findings. F1000prime Rep. 6:692014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rozanski C and Mura M: Multi-dimensional
indices to stage idiopathic pulmonary fibrosis: A systematic
review. Sarcoidosis Vasc Diffuse Lung Dis. 31:8–18. 2014.PubMed/NCBI
|
|
4
|
Upala S and Sanguankeo A: Severity of
breathing disorder during sleep is not correlated with idiopathic
pulmonary fibrosis: A systematic review and meta-analysis. QJM.
109:1412016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koerner-Rettberg C and Ballmann M:
Colistimethate sodium for the treatment of chronic pulmonary
infection in cystic fibrosis: An evidence-based review of its place
in therapy. Core Evid. 9:99–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Figueroa T, Boumart I, Coupeau D and
Rasschaert D: Hyperediting by ADAR1 of a new herpesvirus lncRNA
during the lytic phase of the oncogenic Marek's disease virus. J
Gen Virol. 97:2973–2988. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huarte M: RNA. A lncRNA links genomic
variation with celiac disease. Science. 352:43–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cabianca DS, Casa V and Gabellini D: A
novel molecular mechanism in human genetic disease: A DNA
repeat-derived lncRNA. RNA Biol. 9:1211–1217. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song X, Cao G, Jing L, Lin S, Wang X,
Zhang J, Wang M, Liu W and Lv C: Analysing the relationship between
lncRNA and protein-coding gene and the role of lncRNA as ceRNA in
pulmonary fibrosis. J Cell Mol Med. 18:991–1003. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Q, Han L, Yan W, Ji X, Han R, Yang J,
Yuan J and Ni C: miR-489 inhibits silica-induced pulmonary fibrosis
by targeting MyD88 and Smad3 and is negatively regulated by lncRNA
CHRF. Sci Rep. 6:309212016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sakurai K, Reon BJ, Anaya J and Dutta A:
The lncRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive
nexus. Mol Cancer Res. 13:828–838. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han R, Ji X, Rong R, Li Y, Yao W, Yuan J,
Wu Q, Yang J, Yan W, Han L, et al: MiR-449a regulates autophagy to
inhibit silica-induced pulmonary fibrosis through targeting Bcl2. J
Mol Med (Berl). 94:1267–1279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Renshaw A and Elsheikh TM: A validation
study of the Focalpoint GS imaging system for gynecologic cytology
screening. Cancer Cytopathol. 121:737–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL,
Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, et al: Lentiviral-mediated
miRNA against osteopontin suppresses tumor growth and metastasis of
human hepatocellular carcinoma. Hepatology. 48:1834–1842. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aguileta MA, Rojas-Rivera D, Goossens V,
Estornes Y, Van Isterdael G, Vandenabeele P and Bertrand MJ: A
siRNA screen reveals the prosurvival effect of protein kinase A
activation in conditions of unresolved endoplasmic reticulum
stress. Cell Death Differ. 23:1670–1680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao S, Wang J and Xiao N: MicroRNAs as
noninvasive biomarkers in bladder cancer detection: A diagnostic
meta-analysis based on qRT-PCR data. Int J Biol Markers.
31:e276–e285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kotecha J, Atkins C and Wilson A: Patient
confidence and quality of life in idiopathic pulmonary fibrosis and
sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 33:341–348.
2016.PubMed/NCBI
|
|
19
|
Fu N, Niu X, Wang Y, Du H, Wang B, Du J,
Li Y, Wang R, Zhang Y, Zhao S, et al: Role of LncRNA-activated by
transforming growth factor beta in the progression of hepatitis C
virus-related liver fibrosis. Discov Med. 22:29–42. 2016.PubMed/NCBI
|
|
20
|
Yin S, Zhang Q, Yang J, Lin W, Li Y, Chen
F and Cao W: TGFbeta-incurred epigenetic aberrations of miRNA and
DNA methyltransferase suppress Klotho and potentiate renal
fibrosis. Biochim Biophys Acta. 2017. View Article : Google Scholar
|
|
21
|
Oglesby IK, Agrawal R, Mall MA, McElvaney
NG and Greene CM: miRNA-221 is elevated in cystic fibrosis airway
epithelial cells and regulates expression of ATF6. Mol Cell
Pediatr. 2:12015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Malik R, Patel L, Prensner JR, Shi Y, Iyer
MK, Subramaniyan S, Carley A, Niknafs YS, Sahu A, Han S, et al: The
lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol
Cancer Res. 12:1081–1087. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee CM, Park JW, Cho WK, Zhou Y, Han B,
Yoon PO, Chae J, Elias JA and Lee CG: Modifiers of TGF-β1 effector
function as novel therapeutic targets of pulmonary fibrosis. Korean
J Int Med. 29:281–290. 2014. View Article : Google Scholar
|
|
24
|
Kang HR, Lee JY and Lee CG: TGF-beta1 as a
therapeutic target for pulmonary fibrosis and COPD. Exp Rev Clin
Pharmacol. 1:547–558. 2008. View Article : Google Scholar
|
|
25
|
Xu YD, Hua J, Mui A, O'Connor R,
Grotendorst G and Khalil N: Release of biologically active
TGF-beta1 by alveolar epithelial cells results in pulmonary
fibrosis. Am J Physiol Lung Cell Mol Physiol. 285:L527–L539. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mao Y: Hypermethylation of RASAL1: A key
for renal fibrosis. EBio Med. 2:7–8. 2015.
|
|
27
|
Tao H, Huang C, Yang JJ, Ma TT, Bian EB,
Zhang L, Lv XW, Jin Y and Li J: MeCP2 controls the expression of
RASAL1 in the hepatic fibrosis in rats. Toxicology. 290:327–333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hong Y, Han YQ, Wang YZ, Gao JR, Li YX,
Liu Q and Xia LZ: Paridis Rhizoma Sapoinins attenuates liver
fibrosis in rats by regulating the expression of RASAL1/ERK1/2
signal pathway. J Ethnopharmacol. 192:114–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li S, Xu X, Geng J, Huang X, Jiang D, Zhu
M and Dai H: Role and underlying mechanism of IGF-I/ERK signaling
pathway in lung fibrosis. Zhonghua Yi Xue Za Zhi. 95:1615–1618.
2015.(In Chinese). PubMed/NCBI
|
|
30
|
Leask A: MEK/ERK inhibitors:
Proof-of-concept studies in lung fibrosis. J Cell Commun Signal.
6:59–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zuo WL, Zhao JM, Huang JX, Zhou W, Lei ZH,
Huang YM, Huang YF and Li HG: Effect of bosentan is correlated with
MMP-9/TIMP-1 ratio in bleomycin-induced pulmonary fibrosis. Biomed
Rep. 6:201–205. 2017. View Article : Google Scholar : PubMed/NCBI
|
